PA
ESTC icon

PharVision Advisers’s Elastic ESTC Stock Holding History

PharVision Advisers’s Portfolio ESTC Stock Details ESTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,737
Closed -$315K – 705
2025
Q2 		$315K Buy
3,737
+1,405
+60% +$119K 0.45% 73
2025
Q1 		$208K Sell
2,332
-851
-27% -$88.3K 0.29% 193
2024
Q4 		$315K Buy
+3,183
New +$294K 0.27% 136

Other funds holding ESTC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
SC
Sylebra Capital Palo Alto, California $945M AUM 22.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $24B AUM 39.59% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PharVision Advisers's ESTC Position: Q3 2025 in Review

PharVision Advisers sold out of Elastic (ESTC) in Q3 2025, closing a stake of 3,737 shares — an estimated $315K sold.

PharVision Advisers first reported a position in ESTC in Q4 2024 and held it in 3 quarters. The position peaked at $315K in Q4 2024. 438 funds tracked by Wall St. Rank hold ESTC as of Q3 2025.

  • PharVision Advisers reported no remaining Elastic position as of Q3 2025 after selling out during the quarter.
  • PharVision Advisers sold 3,737 Elastic shares in Q3 2025, an estimated $315K.
  • PharVision Advisers first reported a position in Elastic in Q4 2024 and held it in 3 quarters.
  • PharVision Advisers's Elastic position peaked at $315K in Q4 2024.
  • 438 funds tracked by Wall St. Rank held Elastic as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.